NRF1 and hepatocellular carcinoma: Interestingly, the mining of sequencing data of a cohort of patients with liver hepatocellular carcinoma (LIHC) included in The Cancer Genome Atlas (TCGA) shows that YY1, E2F4, and NRF1 expressions were significantly upregulated in the liver of HCC patients (Supplementary Figure S4).